TGFB1 and pulmonary fibrosis: In summary, several natural compounds have shown the capacity to attenuate pulmonary-fibrosis progression in experimental models by targeting the TGF-β-driven EMT pathway, thereby offering novel therapeutic candidates and mechanistic targets for antifibrotic intervention.